• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黎巴嫩女性卵巢癌:一项为期12年的比较流行病学研究及趋势分析。

Ovarian cancer in Lebanese women: a 12-year comparative epidemiological study and trend analysis.

作者信息

El Kareh Antonio, Safi Steven, Kaady Théa, Hage Said El, Mokled Elie, Assouad Elise, Snaifer Elie, Nader Reine

机构信息

Faculty of Medical Sciences, Lebanese University, Hadath, Lebanon.

Co-first authors.

出版信息

Ecancermedicalscience. 2022 Jun 13;16:1409. doi: 10.3332/ecancer.2022.1409. eCollection 2022.

DOI:10.3332/ecancer.2022.1409
PMID:36072232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9377821/
Abstract

PURPOSE

Over the last decade, Lebanon has experienced an increase in the rate of cancer patients. The aim of this study is to investigate the incidence rates of ovarian cancer in Lebanese women over a period of 12 years and to compare them to other countries.

METHODS

Data were collected from the Lebanese National Cancer Registry for the time period 2005-2016 (inclusive). Data from other countries were retrieved from an online database 'Cancer Incidence in Five Continents'. The age-specific and age-standardised incidence rates (ASIR) were calculated and analysed using Joinpoint regression.

RESULTS

Ovarian cancer ranked seventh among the commonest cancers in Lebanese women in the studied time frame. Approximately 189 new cases were reported every year, with an average age-standardised incidence rate of 7.88 (per 100,000 women). Ovarian cancer showed a significantly decreasing trend in the 12 years of study. Lebanon had one of the highest ASIR for ovarian cancer among regional countries and randomly selected countries.

CONCLUSION

Lebanon presented a high ASIR for ovarian cancer compared to regional countries, and was placed among the top ASIRs compared to countries worldwide. However, with the decreasing ovarian cancer trends, it is important to implement efficacious awareness in order to detect all OC cases.

摘要

目的

在过去十年中,黎巴嫩癌症患者的比例有所上升。本研究的目的是调查黎巴嫩女性在12年期间卵巢癌的发病率,并与其他国家进行比较。

方法

收集了黎巴嫩国家癌症登记处2005 - 2016年(含)期间的数据。其他国家的数据从在线数据库“五大洲癌症发病率”中获取。使用Joinpoint回归计算并分析了年龄特异性和年龄标准化发病率(ASIR)。

结果

在所研究的时间段内,卵巢癌在黎巴嫩女性最常见的癌症中排名第七。每年约报告189例新病例,平均年龄标准化发病率为7.88(每10万名女性)。在12年的研究中,卵巢癌呈显著下降趋势。黎巴嫩在地区国家和随机选择的国家中,卵巢癌的年龄标准化发病率是最高的之一。

结论

与地区国家相比,黎巴嫩卵巢癌的年龄标准化发病率较高,与世界各国相比也处于较高水平。然而,鉴于卵巢癌呈下降趋势,开展有效的宣传以发现所有卵巢癌病例非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/9377821/468bd812f6f4/can-16-1409fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/9377821/b6298666ec5a/can-16-1409fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/9377821/468bd812f6f4/can-16-1409fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/9377821/b6298666ec5a/can-16-1409fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ae6/9377821/468bd812f6f4/can-16-1409fig2.jpg

相似文献

1
Ovarian cancer in Lebanese women: a 12-year comparative epidemiological study and trend analysis.黎巴嫩女性卵巢癌:一项为期12年的比较流行病学研究及趋势分析。
Ecancermedicalscience. 2022 Jun 13;16:1409. doi: 10.3332/ecancer.2022.1409. eCollection 2022.
2
Kidney cancer trends and risk factors in Lebanon: a 12-year epidemiological study.黎巴嫩的肾癌趋势和危险因素:一项 12 年的流行病学研究。
Cancer Causes Control. 2022 Feb;33(2):303-312. doi: 10.1007/s10552-021-01525-y. Epub 2021 Nov 28.
3
Breast Cancer Epidemiology among Lebanese Women: An 11-Year Analysis.黎巴嫩女性乳腺癌流行病学:11 年分析。
Medicina (Kaunas). 2019 Aug 10;55(8):463. doi: 10.3390/medicina55080463.
4
Epidemiology of Breast, Corpus Uteri, and Ovarian Cancers in Lebanon With Emphasis on Breast Cancer Incidence Trends and Risk Factors Compared to Regional and Global Rates.黎巴嫩乳腺癌、子宫体癌和卵巢癌的流行病学,重点分析与区域和全球水平相比的乳腺癌发病率趋势和危险因素。
Cancer Control. 2024 Jan-Dec;31:10732748241236266. doi: 10.1177/10732748241236266.
5
Epidemiological Study of Lung Cancer Incidence in Lebanon.黎巴嫩肺癌发病率的流行病学研究。
Medicina (Kaunas). 2019 May 28;55(6):217. doi: 10.3390/medicina55060217.
6
Probing the Colorectal Cancer Incidence in Lebanon: an 11-Year Epidemiological Study.探究黎巴嫩的结直肠癌发病率:一项为期11年的流行病学研究。
J Gastrointest Cancer. 2020 Sep;51(3):805-812. doi: 10.1007/s12029-019-00284-z.
7
Multiple myeloma in Lebanon: Trend analysis, 10-year projections and comparisons to other countries.黎巴嫩的多发性骨髓瘤:趋势分析、10年预测及与其他国家的比较。
Cancer Treat Res Commun. 2022;30:100513. doi: 10.1016/j.ctarc.2022.100513. Epub 2022 Jan 7.
8
Central nervous system cancers in the Middle East and North Africa (MENA) region: where does Lebanon stand.中东和北非(MENA)地区的中枢神经系统癌症:黎巴嫩处于什么位置。
Chin Clin Oncol. 2020 Jun;9(3):36. doi: 10.21037/cco.2020.04.02. Epub 2020 Apr 23.
9
Colorectal Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Regional and Western Countries.黎巴嫩结直肠癌发病情况:发病率、时间趋势及与地区和西方国家的比较。
Cancer Control. 2021 Jan-Dec;28:1073274821996869. doi: 10.1177/1073274821996869.
10
Bladder Cancer in Lebanon: Incidence and Comparison to Regional and Western Countries.黎巴嫩的膀胱癌:发病率及与地区和西方国家的比较。
Cancer Control. 2018 Jan-Dec;25(1):1073274818789359. doi: 10.1177/1073274818789359.

引用本文的文献

1
Breast and Ovarian Cancers' Incidence Trends Among Iraqi Women During 2012-2022 and Their Relationship to Fertility Patterns.2012 - 2022年伊拉克女性乳腺癌和卵巢癌的发病趋势及其与生育模式的关系
Sultan Qaboos Univ Med J. 2025 May 2;25(1):499-505. doi: 10.18295/2075-0528.2863. eCollection 2025.

本文引用的文献

1
Impact of parity on the incidence of ovarian cancer subtypes: a population-based case-control study.生育对卵巢癌亚型发病的影响:基于人群的病例对照研究。
Acta Oncol. 2021 Jul;60(7):850-855. doi: 10.1080/0284186X.2021.1919754. Epub 2021 May 17.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
长链非编码 RNA CHRF 在顺铂耐药卵巢癌中的新作用是通过 miR-10b 诱导的 EMT 和 STAT3 信号传导介导的。
Sci Rep. 2020 Sep 8;10(1):14768. doi: 10.1038/s41598-020-71153-0.
4
Good news on the active management of pregnant cancer patients.关于对妊娠癌症患者进行积极治疗的好消息。
F1000Res. 2020 Jun 1;9. doi: 10.12688/f1000research.22472.1. eCollection 2020.
5
Use of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.BRCA 基因突变携带者中口服避孕药的使用与卵巢癌和乳腺癌风险:系统评价。
Arch Gynecol Obstet. 2020 Apr;301(4):875-884. doi: 10.1007/s00404-020-05458-w. Epub 2020 Mar 5.
6
Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis.全球卵巢癌发病率的模式和趋势:年龄、时期和出生队列分析。
BMC Cancer. 2019 Oct 22;19(1):984. doi: 10.1186/s12885-019-6139-6.
7
Breast Cancer Epidemiology among Lebanese Women: An 11-Year Analysis.黎巴嫩女性乳腺癌流行病学:11 年分析。
Medicina (Kaunas). 2019 Aug 10;55(8):463. doi: 10.3390/medicina55080463.
8
Assessment of the awareness and usages of family planning methods in the Lebanese community.黎巴嫩社区计划生育方法的知晓率及使用情况评估。
BMJ Sex Reprod Health. 2019 Aug 8. doi: 10.1136/bmjsrh-2018-200067.
9
Ovarian cancer in the world: epidemiology and risk factors.全球卵巢癌:流行病学与风险因素
Int J Womens Health. 2019 Apr 30;11:287-299. doi: 10.2147/IJWH.S197604. eCollection 2019.
10
Contraceptive use in Latin America and the Caribbean with a focus on long-acting reversible contraceptives: prevalence and inequalities in 23 countries.拉丁美洲和加勒比地区的避孕措施使用情况,重点关注长效可逆避孕方法:23 个国家的流行情况和不平等现象。
Lancet Glob Health. 2019 Feb;7(2):e227-e235. doi: 10.1016/S2214-109X(18)30481-9.